… as third-line treatment agent in non-oncogene driven … In the univariate analysis, there was
a significant difference in the … ), such as gefitinib, afatinib, and erlotinib, are recommended …

… Docetaxel, pemetrexed, erlotinib, and gefitinib are … In this paper, we present an NMA
comparing the relative efficacy … including both second- and third-line therapy, because there is no …

… -kinase inhibitor erlotinib has proven efficacy and tolerability in … a basic comparison of the
two treatment groups (erlotinib versus … in the BR.21 study of second-line and third-line erlotinib. …

… ) compared with placebo when used as second- or third-line … patients received chemotherapy
(including gefitinib treatment in 2 … the efficacy and safety of erlotinib as second- or third-line …

… as first-line therapies in targeted therapy research include erlotinib (8) and gefitinib (9); …
, the present study indicated that, compared with the control group, the third-line treatment of …

… III trials reporting the efficacy of gefitinib or erlotinib as maintenance therapy (single or …
to detect the difference in OS. Also, the widespread use of second and third line treatment at …

… reported that, compared with gefitinib, erlotinib possesses an … reported that gefitinib and
erlotinib have similar efficacies (12… toxicity compared with gefitinib for the treatment of advanced …

… support the use of erlotinib and gefitinib as late-line therapy. … study (INTEREST) comparing
gefitinib and docetaxel, the … survival after second- or third-line gefitinib was 14.2 months in …

… review focuses on the toxicity differences and predictors of … data have not established the
efficacy of the weekly regimen … erlotinib for patients with recurrent non-small-cell lung cancer…

… the gefitinib (P=0.008), erlotinib, icotinib, and only OS in gefitinib … the OS times of patients
compared to placebo. However, the … treatments had no impact on the efficacy of anlotinib in …